Cytokinetics Inc (NASDAQ:CYTK)

Data as of Sep 19
 +0.28 / +7.25%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Cytokinetics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its current research and development programs relating to the biology of muscle function are directed to small molecule modulators of the contractility of cardiac, skeletal and smooth muscle. Cytokinetics was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Contact Information

Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco California 94080
P:(650) 624-3000
Investor Relations:
(650) 624-3060



Individual stakeholders8.16%
Other institutional50.85%
Mutual fund holders16.57%

Top Executives

Robert I. BlumPresident, Chief Executive Officer & Director
Sharon A. BarbariChief Financial Officer, Secretary & Executive VP
Fady Ibraham MalikSenior Vice President-Research & Early Development
Andrew A. WolffChief Medical Officer & Senior Vice President
Elisabeth A. SchniedersVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.